Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JDM is an international journal dedicated to the current developments of Diabetes Mellitus, the broad scope will also include significant research in the fields of pathology and therapeutic innovations of diabetes itself, both type I and II. All manuscripts submitted to JDM must be previously unpublished and may not b…
Ikia Monde Valsy Russelh, Evariste Bouenizabila, Farel Elilie Mawa Ongoth, Raissa Laure Mayanda Ohouna, Aymande Okoumou-Moko, Paulin Kibeke, Ghislain Loubano-Voumbi, Luc Magloire Boumba Anicet, Wilson Fabrice Ondongo, Mayindou Kimbangu Archimède Gotran, Tienelle Freiss Mabiala Wann, Koumou Onanga, Thierry Raoul Ngombea, Benjamin Longo Mbenza, Edouard Ngou Milama, Christian Andres, Etienne Mokondjimobe, Henri Germain Monabeka
Background: Type 2 diabetes (T2D) remains a major global public health problem. This complex metabolic disorder can lead to various complications, including cardiovascular diseases (leading cause of death) in T2D. Among the biochemical markers associated with…
Rosemary Temidayo Ikem, Ugochukwu Rosemary Mosanya, Gbadebo Oladimeji David Ajani, Okechukwu Obumneme Ezekpo, David Olubukunmi Soyoye
Background: Obesity is rising globally, independent of ethnicity, race and age, and is associated with increased risk of cardiovascular mortality and morbidity especially in persons living with diabetes. The effect of adipokines such as leptin, resistin and a…
Annelie Kerekou Hode, Hubert Alihonou Dedjan, Aurel Mazaman-Esso Lantokpode
Erectile dysfunction was one of the most common complications in diabetic patients. According to several studies, its prevalence was two to three times higher in diabetics than in the general population. But it has often been overlooked despite the fact that…
Ali Alromaih, Abdullah Alshamrani, Bandar Alharbi, Ibtissam Alharbi, Turki Alharbi, Samia Bokhari, Hussein Elbadawi, Mohammed Almehthel, Abdulghani Alsaeed, Khalid Alyahia, Fatimah Alhowyan, Marc Evans, Roopa Mehta, Emad Issak, Saud Alsifri
GLP-1 receptor agonists (GLP-1 RAs) are among the most successful medications for treating people with type 2 diabetes mellitus (T2DM), giving reasonable glycemic control with a low risk of hypoglycemia in those who have failed to control their condition with…
Guluzar Arzu Turan, Tuncay Delibasi
Gestational diabetes mellitus (GDM) is one of the most common pregnancy complications which affect the mother and offspring. In addition to adverse perinatal outcomes, it may lead to permanent health problems for the mother, such as type 2 diabetes mellitus (…
Momar Dioum, Binta Gueye, Ismael Ibouroi Moina-Hanifa, Cheikh Gaye, Joseph Salvador Mingou, Aliou A. Ngaide, Awa Kane, Maboury Diao
Introduction: Cardiovascular diseases (CVD) are the most important cause of morbidity and mortality in type 2 diabetes (T2D). The objective of this study was to describe the profile of cardiovascular diseases of diabetics admitted at the cardiology department…
Josephine Sekai Tityiwe, Newton-Hughes Anne, Azangwe Godfrey, Comfort Paul
The aim of this study was to compare lower limb blood flow in asymptomatic diabetic patients with early-stage peripheral artery disease (PAD) and non-diabetic controls using duplex ultrasound parameters. This was a comparative cohort study of lower limb blood…
Richard Evers Katholi, Marcella Rene Ervin
Magnesium deficiency is common in patients with type 2 diabetes mellitus (type 2 DM). When adequate magnesium supplementation is chronically given, patients with type 2 DM appear to have improved glucose control and may have delayed chronic complications. In…
Angelos Karavasilis, Petros Karkalousos, Maria Trapali, Christina Fountzoula, George Albert Karikas
One of the most fundamental molecular processes in response to hypoxia is the activation and stabilization of a transcriptional factor called hypoxia induced factor 1a (HIF-1a), which is responsible for the regulation of many downstream effector genes. Multip…
Anjali Vijaya, Subhash Kumar
Objective: The main aim of the survey was to assess diabetes treatment-related myths prevalent in the Indian population and if COVID-19 pandemic improved their knowledge about diabetes. Results: The survey was completed by 309 participants; 66% did not have d…
No articles in this issue.
JDM is an international journal dedicated to the current developments of Diabetes Mellitus, the broad scope will also include significant research in the fields of pathology and therapeutic innovations of diabetes itself, both type I and II. All manuscripts submitted to JDM must be previously unpublished and may not b… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).